SEC Filing Details

Form
4
Filing Date
June 18, 2024
Document Date
June 16, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Atea Pharmaceuticals, Inc.
Issuer
Atea Pharmaceuticals, Inc.
Filer
MURPHY POLLY A.

Atea is a clinical-stage biopharmaceutical company working to address unmet medical needs through novel antiviral treatment.

Copyright © 2024 By Atea Pharmaceuticals, Inc. All Rights Reserved. Privacy Policy | Terms of Use